Suppr超能文献

降钙素基因相关肽和肾上腺髓质素受体的胞外结构域。

Ectodomain structures of the CGRP and AM receptors.

机构信息

RIKEN Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.

出版信息

Curr Protein Pept Sci. 2013 Aug;14(5):375-85. doi: 10.2174/13892037113149990054.

Abstract

Receptor activity-modifying proteins (RAMPs) 1-3, which are classified as type I transmembrane proteins, serve as the partner proteins of several family B GPCRs for physiologically active peptides, including the calcitonin receptor- like receptor (CLR). The properties of the GPCRs are defined by the RAMP and peptide ligand combination. The CLR•RAMP1 heterodimer functions mainly as the calcitonin gene-related peptide (CGRP) receptor, while the CLR•RAMP2 and CLR•RAMP3 heterodimers primarily function as the adrenomedullin 1 and adrenomedullin 2 (AM₁ and AM₂) receptors, respectively. The crystal structures of the RAMP1 and RAMP2 ectodomains exhibited three-helix bundles, and those of their complexes with the N-terminal extracellular domain of CLR revealed how the two ectodomains associate to form the CGRP and AM₁ receptors, respectively. On this structural framework, the various intermolecular interactions of CLR with RAMP1 and RAMP2 result in the distinct shapes of the putative ligand-binding sites, where several residues are uniquely presented. Therefore, the differences in the shapes and the presented residues of the binding sites determine the specificities of the receptors to either CGRP or AM. These structural features of the ectodomains are consistent with mutagenesis results, and are useful to further examine the binding modes of the peptide ligands to the full-length CGRP and AM₁ receptors.

摘要

受体活性修饰蛋白(RAMPs)1-3 被归类为 I 型跨膜蛋白,作为几种 B 族 G 蛋白偶联受体(GPCR)的伴侣蛋白,为生理活性肽提供服务,包括降钙素受体样受体(CLR)。GPCR 的特性由 RAMP 和肽配体的组合决定。CLR•RAMP1 异二聚体主要作为降钙素基因相关肽(CGRP)受体发挥作用,而 CLR•RAMP2 和 CLR•RAMP3 异二聚体主要作为肾上腺髓质素 1(AM₁)和肾上腺髓质素 2(AM₂)受体发挥作用。RAMP1 和 RAMP2 外结构域的晶体结构呈现出三螺旋束,其与 CLR 的 N 端细胞外结构域复合物的结构揭示了两个外结构域如何分别形成 CGRP 和 AM₁ 受体。在这个结构框架上,CLR 与 RAMP1 和 RAMP2 的各种分子间相互作用导致了假定的配体结合位点的独特形状,其中有几个独特的残基呈现出来。因此,结合位点的形状和呈现出来的残基的差异决定了受体对 CGRP 或 AM 的特异性。这些外结构域的结构特征与突变结果一致,有助于进一步研究全长 CGRP 和 AM₁ 受体中肽配体的结合模式。

相似文献

引用本文的文献

1
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.受体活性调节蛋白(RAMPs):新见解与作用
Annu Rev Pharmacol Toxicol. 2016;56:469-87. doi: 10.1146/annurev-pharmtox-010715-103120. Epub 2015 Oct 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验